Opinion in Sweden

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
ResearchWire
ResearchWire

3G mobile infrastructure: Orange to share Swedish network costs

Published By Datamonitor
16 Jan 2002
ResearchWire
ResearchWire

3G mobile phones: 31 million European subscribers in 2005

Published By Datamonitor
06 Mar 2001
CommentWire
CommentWire

3G/wLANs: co-operation rather than competition

Published By Datamonitor
24 Oct 2001
CommentWire
CommentWire

Alcohol trade: legal changes to benefit Swedish drinkers

The European Commission has told Sweden it must relax its laws concerning alcohol purchases from abroad, on the grounds that they currently constitute a barrier to trade. While the move will undoubtedly delight Swedish natives, one market set to reap the benefit will be Denmark - especially Carlsberg [CARLb.CO].

Published By Datamonitor
22 Oct 2003
CommentWire
CommentWire

Alstom: slimming down to survive

Siemens has bought Alstom's industrial turbines business. At E1.1 billion, Alstom has secured a good price for the unit. The sale also means that its E3 billion disposal program is off to an encouraging start. Much work remains to be done, however, if the company is to survive its E5 billion debt burden.

Published By Datamonitor
30 Apr 2003
CommentWire
CommentWire

Alzheimer's disease: testing times for those at risk

Long-term studies have shown biomarkers to be effective in predicting those with mild cognitive impairment that will go on to develop Alzheimer's disease. Such a test could help companies developing new therapies for delaying or preventing the onset of Alzheimer's, and, by identifying the need for treatment early, could improve both drug uptake and treatment success rates.

Published By Datamonitor
07 Feb 2006
CommentWire
CommentWire

AstraZeneca: Arimidex is the new gold standard

The cancer drug showed outstanding results compared to the current gold standard, tamoxifen. Indeed, Arimidex could be the ideal aromatase inhibitor - and judging by these results, AstraZeneca's marketing power will ensure that the drug becomes a major cancer product.

Published By Datamonitor
19 Feb 2002
CommentWire
CommentWire

AstraZeneca: new software should speed drug discovery

Published By Datamonitor
23 Aug 2001
ResearchWire
ResearchWire

Automated email response: Ireland will take the lead

Published By Datamonitor
07 Mar 2001
CommentWire
CommentWire

Bewag: split ownership expected to be approved

Published By Datamonitor
27 Apr 2001

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.